KUKJE PHARMA (002720.KS) Earnings Analysis
KUKJE PHARMA (002720.KS) has no confirmed upcoming earnings date. Trailing P/E 11.54.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 002720.KS next report earnings?
No confirmed upcoming earnings date is currently scheduled for 002720.KS. This page updates as the calendar is published.
002720.KS earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2024-12-31 | 34.76 KRW | n/a | n/a | n/a |
| 2024-09-30 | 57 KRW | n/a | n/a | n/a |
002720.KS valuation and analyst view
| Trailing P/E | 11.54 |
|---|---|
| Trailing EPS | 283.2 KRW |
| Price / book | 0.72 |
| Dividend yield | 0.89% |
| Market cap | 70.25B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is KUKJE PHARMA (002720.KS)'s next earnings date?
No confirmed upcoming earnings date is currently scheduled for 002720.KS. This page updates as the calendar is published.
Did 002720.KS beat earnings last quarter?
Consensus estimate data was not available for 002720.KS's 2024-12-31 report.
What is 002720.KS's current P/E ratio and EPS?
002720.KS trades at a trailing P/E of 11.54 on trailing EPS of 283.1950058488177 KRW.
What do analysts rate 002720.KS?
002720.KS has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.